CFO Luke Power said the company’s strong revenue performance continued to translate into profitability despite increased investment. Operating expenses were $136 million, up from $132 million in Q4, and capital expenditures were just over $10 million, up from $5.1 million in Q4. Power noted free cash flow of $23 million for the quarter included annual bonus payments of $30.5 million.Brilly said revenue growth reflected both higher volume and higher pricing: 15% volume growth and a 61% increase in clinical a ...